Navigation Links
Almac and the Royal Society of Chemistry Host a Workshop on the use of Analytical Techniques to Control and Monitor Solid Form

Almac and the Royal Society of Chemistry Host a Workshop on... -- CRAIGAVON, Northern Ireland, November 19, 2010 /PRNewswire/ --

Advanced Search Search

  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Biotechnology, Medical Pharmaceuticals, Pharmaceuticals, Chemical, New Products & Services, Trade Show News Click to view news release full screen  

Almac and the Royal Society of Chemistry Host a Workshop on the use of Analytical Techniques to Control and Monitor Solid Form


CRAIGAVON, Northern Ireland, November 19, 2010 /PRNewswire/ -- Almac, in association with the Royal Society of Chemistry, hosted a scientific workshop focusing on advanced analytical techniques used to optimise, monitor and control solid state properties during the development of new medicines.

The milestone event, attended by representatives from industry and academia, included presentations and round table discussion regarding x-ray powder diffraction, hyper differential scanning calorimetry and Raman spectroscopy.

An important element of the workshop was the presentation of results from Almac's collaborative research with Queens University Belfast regarding Raman spectroscopy. 'The effect of crystal orientation on Raman Spectra' has been observed for the first time and these findings will have profound implications for the use of this technique in characterising physical forms.

Linda McCausland, Head of Physical Sciences, Almac, commented: "Almac has invested extensively in research and development in the field of solid state science and is currently involved in a number of academic collaborations. The research output of these studies will be available to clients to augment the development of their drugs. This workshop provided an opportunity for Almac to share its expertise with the pharmaceutical community and we are very proud to have worked with the Royal Society of Chemistry in staging such an exciting event."

She added: "The insight harnessed from the study's findings is testimony to Almac's status as a leader in the field of solid state science."

Prof Duncan Burns, Analytical Division, Royal Society of Chemistry, remarked: "The workshop was a truly memorable day of excellent and well presented analytical science."

Notes to Editors:

About Almac

The Almac Group offers a broad range of services from R&D, biomarker discovery and development, API manufacture, formulation development, clinical trial supply and IXRS technology (IVRS/IWRS), to commercial-scale manufacture. Almac provides services to more than 600 companies, including all the world leaders in the pharmaceutical and biotech sectors. The company employs almost 3,000 individuals and is headquartered in Craigavon, Northern Ireland. US operations are based in Pennsylvania, North Carolina and California. Almac has officially gained full possession of its new $120m North American Headquarters which started in July 2008 and employees will relocate during the fall.

For more information on Almac, please visit

Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Almac Continues Biocatalysis Business Growth With a Further $4m R&D Investment
2. Almacs North American Headquarters Opens its Doors for Audits
3. Almacs Clinical Technologies Division Undergoes Successful Joint GCP-GMP MHRA Inspection
4. Almac Launch Biomarkers for Biopharma
5. Royalty Pharma Announces that Alexander von Perfall Joins Management Team
6. Unilens Vision Reports Record First Quarter Earnings and Royalty Income
7. Royal Institute of Technology Adopts OriGene Over-Expression Lysates in Human Proteome Atlas Program
8. Neurobiological Technologies Reports Receipt of $1.5 Million Royalty Payment for Quarterly Sales of Memantine
9. Beckman Coulter Buys Out Royalty Obligation for Preeclampsia Markers
10. Alseres Pharmaceuticals Enters Agreement to Amend Cethrin(R) License to Lower Milestone Payments and Royalty Rates
11. Paul Capital Healthcare Purchases Additional Royalty Interest in GlaxoSmithKlines Rotarix(R)
Post Your Comments:
(Date:11/26/2015)... , November 26, 2015 ... Juntendo universitetssjukhus ser potential att använda SyMRI ... (MR-bilder) för patienter med multipel skleros ... forskningsavtal med SyntheticMR AB för att kunna ... på sjukhuset. Med SyMRI kan man generera ...
(Date:11/26/2015)... DUBLIN , November 26, 2015 ... has announced the addition of the  ... in the European Therapeutic Drug Monitoring ... Forecasts, Competitive Intelligence, Emerging Opportunities"  report ... ) has announced the addition ...
(Date:11/26/2015)... November 26, 2015 ... "Self Administration of High Viscosity Drugs" report ... has announced the addition of the "Self ... their offering. --> Research and Markets ... the "Self Administration of High Viscosity Drugs" ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... November 25, 2015 , ... ... all, Water For Empowerment ™ attracts volunteers together who want to combine ... empowering women as key stakeholders in the process. The non-profit launched its first ...
(Date:11/25/2015)... ... 2015 , ... TyloHelo Inc , North America’s largest ... accessories help improve the bather experience in the sauna, and the accessories selected ... purist looking for simplicity in design to accessories that encourage a greater expression ...
(Date:11/25/2015)... ... November 25, 2015 , ... For the first time, Vitalalert is donating ... Beat ” campaign. The partnership between the two groups began in 2014 with Vitalalert ... cause. , MAP International was founded in 1954 and is an international Christian-based health ...
(Date:11/25/2015)... ... ... On November 25, 2015, officials of Narconon Arrowhead , the drug rehabilitation ... new cutting edge recovery program that has been 50 years in the making. ... with the purpose to free addicts from the symptoms and negative behaviors of addiction. ...
(Date:11/25/2015)... ... 2015 , ... Smiles by Stevens is pleased to announce the ... While many patients are aware of the benefits of Botox® in the treatment of ... suffering with discomfort, soreness, and pain as a result of Jaw Tension, TMJ (temporo-mandibular ...
Breaking Medicine News(10 mins):